COVID-19 (Novel Coronavirus) and Sponsored Research

The Office of Sponsored Programs Administration (OSPA) continues to closely follow the COVID-19 outbreak. This page contains information about COVID-19 as it relates to the conduct of research and sponsored projects. This webpage will continue to be updated frequently as new information is received. 

COVID Funding Opportunities

Availability of OSPA Staff

Operations in OSPA are normal until further notice. Continue to contact your Sponsored Programs Officer for most matters. Communications will be sent via email listservs and posted on this website if there are changes.

Allowability of costs

The Office of Sponsored Programs Administration (OSPA) is reviewing questions relating to the allowability of costs associated with any disruptions to sponsored projects stemming from the coronavirus.

  • Send questions to your Sponsored Program Officer.
  • In order for a cost to be allowable, it will require consistent treatment across all funding sources.
  • The federal funding agencies are working on a unified message on these matters. Once it is published, OSPA will share it with the RU community.
Guidance and FAQs from DOD/USAMRAA/CDMRP
Please see this webpage with FAQs for awardees and applicants.  
 
Guidance From NSF on Coronavirus 
NSF has established a webpage with guidance specific to their agency with information for awardee organizations, researchers, and reviewers. If you have questions, please feel free to contact your Sponsored Programs Officer. 
 
Guidance From NIH on Coronavirus and FAQs
NIH has issued the following Notices with guidance for applicants, awardees, and institutions. If you have additional questions, please contact your Sponsored Programs Officer.
 
NIH LATE APPLICATION POLICY Due to Public Health Emergency for United States for 2019 Novel Coronavirus (COVID-19) (NOT-OD-20-082)

General Frequently Asked Questions (FAQs) - Proposal Submission and Award Management Related to COVID-19 (NOT-OD-20-083)

Flexibilities Available to Applicants and Recipients of Federal Financial Assistance Affected by COVID-19
(NOT-OD-20-086)

Guidance for NIH-funded Clinical Trials and Human Subjects Studies Affected by COVID-19  
(NOT-OD-20-087)

Guidance From EMBO 
EMBO has established a webpage with guidance specific to their agency. If you have questions, please feel free to contact your Sponsored Programs Officer.